Autologous stem cells derived from bone marrow: Application in the treatment of premature ovarian failure

Authors

  • Soumya Kamal, Rashmi Mishra, Pratibha Pandey, Fahad Khan ,Prabhu Chandra Mishra Author

DOI:

https://doi.org/10.48047/

Keywords:

Miscarriage, ovarian failure, dysfunction.

Abstract

Premature ovarian failure is characterized by early menopausal symptoms, irregular ovarian development,
and inability to conceive. Miscarriage due to a genetic or autoimmune disorder, surgery, or chemotherapy
may both induce premature ovarian failure. The application of stem cells to the body is successful in the
treatment of premature ovarian ageing. Since stem cells can self-renew, proliferate, and regenerate into
other cells, tissues, and organs in the human body, they are a potential therapeutic choice for women
suffering from ovarian dysfunction. Miscarriage due to a genetic or autoimmune disorder, surgery, or
chemotherapy may both induce premature ovarian failure. The application of stem cells to the body is
successful in the treatment of premature ovarian ageing. Since stem cells can self-renew, proliferate, and
regenerate into other cells, tissues, and organs in the human body, they are a potential therapeutic choice
for women suffering from ovarian dysfunction. 

Downloads

Download data is not yet available.

Downloads

Published

2021-03-13